Bibliografia

1. Kim YH, Kim DH, Lim H, et al. The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammatory responses in murine macrophages. Biol Pharm Bull 2009; 32(4): 651-6.
2. Notarnicola A, Tafuri S, Fusaro L, et al. The “MESACA” study: methylsulfonylmethane and boswellic acids in the treatment of gonarthrosis. Adv Ther 2011; 28(10): 894-906.

Ulteriori aprrofondimenti

• Cichoke AJ. Zinc: the free radical zapper. Health Foods Business 1994; 47.
• Fabris N, Mocchegiani E. Zinc, human diseases and aging. Aging Clin Exp Res 1995; 7(2): 77-93.
• Germano C, Cabot W. Nature’s pain killers. Kensington Publishing Corporation, 1999.
• Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee”.  Osteoarthritis Cartilage 2005; 14(3):286-94.
• Lawrence RM. Methyl-sulfonyl-methane (MSM): a double-blind study of its use in degenerative arthtritis. International J. of anti-aging Medicine 1998; I (I): 50.
• Lawrence RM, Sanchez D. Grosman M Lignisul MSM in the treatment of acute athletic injuries. Nutrition and Health Research 2001.
• Lentner C. Geigy Scientific tables. Biochemistry.  Vol 4. Ciba_Geigy, 1986; pp 190-6.
• Pandani M, Wats D. Guida al corretto utilizzo di vitamine e minerali nella nutrizione. Milano: Tecniche Nuove, 1991; pp 103-7.
• Rainsford KD. Environmental metal ion perturbations, especially as they affect Copper status are a factor in the etiology of arthritic conditions. Inflammatory Diseases and Copper
• Experimental Biology and Medicine 1982; 2: 137-43.
• Richmond VL. Incorporation of Methylsulfonylmethane sulfur into guinea pig serum proteins. Life Sciences 1986;  39: 263-8.
• Sontakke S, Thawani V, Pimpalkhute S, Kabra P, Babhulker S. Open, randomized, controlled clinical trial of Boswellia Serrata extract as compared to valdecoxib in ostheoarthritis of knee. Indian J Pharmacol, 2007; 39(1): 27-9.